News
Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
1don MSN
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
The company says its vaccine is on track for full approval, following delay. Novavax shares soared following the announcement ...
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
The U.S. Food and Drug Administration (FDA) is still negotiating whether to grant full approval to Novavax's COVID-19 vaccine ...
Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results